Iaculor is focusing on the development and commercialization of next generation needle-free medical devices for the delivery of drugs or vaccines in either liquid or powder form. The company's short term goal is to complete the development of its initial products and establish strategic partnerships for their production and commercialization. Iaculor will offer pharmaceutical and medical device companies products that are precise, effective, safe, low-cost and simple to use. Iacular was spun out of the University of Sherbrooke in 2006.